RXO (NYSE: RXO) reported Q3 EPS of $0.05, $0.03 better than the analyst estimate of $0.02. Revenue for the quarter came in at $976 million versus the consensus estimate of $965.56 million.

For earnings history and earnings-related data on RXO (RXO) click here.